by MM360 Staff | May 27, 2025 | Uncategorized
Source: CureToday articles A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy. Read More
by MM360 Staff | May 27, 2025 | Uncategorized
Source: CureToday articles Education and patient advocacy are essential to improving care in Waldenström macroglobulinemia amid clinical advances, according to Dr. Shirley D’Sa. Read More
by MM360 Staff | May 27, 2025 | Uncategorized
Source: CureToday articles Connecting with nature through journaling, walking and meditation helped me heal during and after colon cancer treatment. Read More
by MM360 Staff | May 27, 2025 | Uncategorized
Source: CureToday articles A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation portion of the clinical trial. Read More
by MM360 Staff | May 27, 2025 | Uncategorized
Source: CureToday articles The first patient has received treatment with mavrostobart plus chemo in the phase 1/2 MORNINGSTAR trial for advanced solid tumors, including lung cancer. Read More
by MM360 Staff | May 27, 2025 | Uncategorized
Source: CureToday articles Dr. Tiziano Barbui explains how excess blood cell production in certain myeloproliferative neoplasms can impair circulation and why treatments like phlebotomy are used. Read More